Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Contraception and Contraceptive Drugs

Free Subscription Articles published in Gynecol Endocrinol Retrieve available abstracts of 80 articles: HTML format

Single Articles

September 2020
1. ZHAO Y, Luan X, Wang Y
   Letrozole combined with oral contraceptives versus oral contraceptives alone in the treatment of endometriosis-related pain symptoms: a pilot study.
   Gynecol Endocrinol. 2020 Sep 16:1-5. doi: 10.1080/09513590.2020.1807502.
   PubMed     Abstract available
   
   
   August 2020
2. MASSAROTTI C, Lo Monaco L, Scaruffi P, Sozzi F, et al
   Contraception in cancer survivors: insights from oncofertility follow-up visits.
   Gynecol Endocrinol. 2020 Aug 25:1-5. doi: 10.1080/09513590.2020.1810658.
   PubMed     Abstract available
   
   
   
3. NAPPI RE, Tiranini L
   "50 Shades of sex" under hormonal contraception.
   Gynecol Endocrinol. 2020 Aug 21:1-2. doi: 10.1080/09513590.2020.1811847.
   PubMed    
   
   
   June 2020
4. BATTAGLIA C, Battaglia B, Casadio P, Rizzo R, et al
   Metformin metabolic and vascular effects in normal weight hyperinsulinemic polycystic ovary syndrome patients treated with contraceptive vaginal ring. A pilot study.
   Gynecol Endocrinol. 2020 Jun 16:1-8. doi: 10.1080/09513590.2020.1770213.
   PubMed     Abstract available
   
   
   
5. STEFANIAK A, Domitrz J, Siewko K, Szelachowska M, et al
   Pituitary adenoma and apoplexy during GnRH agonist treatment for IVF - case report.
   Gynecol Endocrinol. 2020;36:561-563.
   PubMed     Abstract available
   
   
   May 2020
6. LANDERSOE SK, Larsen EC, Forman JL, Birch Petersen K, et al
   Ovarian reserve markers and endocrine profile during oral contraception: Is there a link between the degree of ovarian suppression and AMH?
   Gynecol Endocrinol. 2020 May 2:1-6. doi: 10.1080/09513590.2020.1756250.
   PubMed     Abstract available
   
   
   
7. DEL FORNO S, Degli Esposti E, Salucci P, Leonardi D, et al
   Liver function, tolerability and satisfaction during treatment with ulipristal acetate in women with fibroids: a single center experience.
   Gynecol Endocrinol. 2020;36:445-447.
   PubMed     Abstract available
   
   
   April 2020
8. LASORELLA S, Porto R, Iezzi ML, Pistone C, et al
   Comparison of triptorelin acetate vs triptorelin pamoate in the treatment of Central precocious puberty (CPP): a retrospective study.
   Gynecol Endocrinol. 2020;36:338-340.
   PubMed     Abstract available
   
   
   February 2020
9. BARRIGA POOLEY P, Von Hoveling A, Galan G, Lopez Berroa J, et al
   Analysis and new contraception frontiers with combined vaginal rings.
   Gynecol Endocrinol. 2020 Feb 24:1-4. doi: 10.1080/09513590.2020.1729730.
   PubMed     Abstract available
   
   
   
10. HADJI P, Neulen J, Schaudig K, Schwenkhagen A, et al
    Extended-cycle versus conventional treatment with a combined oral contraceptive containing ethinylestradiol (30 mug) and levonorgestrel (150 mug) in a randomized controlled trial.
    Gynecol Endocrinol. 2020 Feb 16:1-8. doi: 10.1080/09513590.2020.1725963.
    PubMed     Abstract available
    
    
    December 2019
11. PALAIA I, Del Negro V, Fracassi A, Schiavi M, et al
    Efficacy of ulipristal acetate (UPA) for the treatment of expulsion uterine myomas: report of two cases.
    Gynecol Endocrinol. 2019 Dec 26:1-2. doi: 10.1080/09513590.2019.1707795.
    PubMed     Abstract available
    
    
    
12. XHOLLI A, Filip G, Previtera F, Cagnacci A, et al
    Modification of endometrioma size during hormone therapy containing dienogest.
    Gynecol Endocrinol. 2019 Dec 16:1-5. doi: 10.1080/09513590.2019.1703942.
    PubMed     Abstract available
    
    
    November 2019
13. FERRERO S, Scala C, Ciccarelli S, Vellone VG, et al
    Treatment of rectovaginal endometriosis with the etonogestrel-releasing contraceptive implant.
    Gynecol Endocrinol. 2019 Nov 12:1-5. doi: 10.1080/09513590.2019.1689552.
    PubMed     Abstract available
    
    
    October 2019
14. MATSUSHIMA T, Akira S, Yoneyama K, Takeshita T, et al
    Recurrence of uterine adenomyosis after administration of gonadotropin-releasing hormone agonist and the efficacy of dienogest.
    Gynecol Endocrinol. 2019 Oct 29:1-4. doi: 10.1080/09513590.2019.1683818.
    PubMed     Abstract available
    
    
    September 2019
15. WALLNER C, Rausch A, Drysch M, Dadras M, et al
    Regulatory aspects of myogenic factors GDF-8 and Follistatin on the intake of combined oral contraceptives.
    Gynecol Endocrinol. 2019 Sep 17:1-7. doi: 10.1080/09513590.2019.1666816.
    PubMed     Abstract available
    
    
    August 2019
16. PALAIA I, Bardhi E, Boccia SM, Pecorini F, et al
    Severe hemoperitoneum due to endometriosis in a non-pregnant woman under dienogest therapy: a case report.
    Gynecol Endocrinol. 2019 Aug 13:1-2. doi: 10.1080/09513590.2019.1653843.
    PubMed     Abstract available
    
    
    
17. GIARRE G, Franchini M, Castellacci E, Malune ME, et al
    Ulipristal acetate in symptomatic uterine fibroids. A real-world experience in a multicentric Italian study.
    Gynecol Endocrinol. 2019 Aug 8:1-4. doi: 10.1080/09513590.2019.1648419.
    PubMed     Abstract available
    
    
    July 2019
18. BISCIONE A, Barra V, Bellone E, Severi FM, et al
    Ulipristal acetate on quality of life and sexual function of women with uterine fibromatosis.
    Gynecol Endocrinol. 2019 Jul 22:1-6. doi: 10.1080/09513590.2019.1640202.
    PubMed     Abstract available
    
    
    
19. GUIDA M, Rega A, Vivone I, Saccone G, et al
    Variations in sleep associated with different types of hormonal contraceptives.
    Gynecol Endocrinol. 2019 Jul 17:1-5. doi: 10.1080/09513590.2019.1640204.
    PubMed     Abstract available
    
    
    
20. RIZZELLO F, Ralli E, Romanelli C, Coccia ME, et al
    Severe recurrent endometriomas in a young woman with congenital von Willebrand disease.
    Gynecol Endocrinol. 2019 Jul 16:1-3. doi: 10.1080/09513590.2019.1641481.
    PubMed     Abstract available
    
    
    
21. ANGIONI S, Pontis A, Malune ME, Cela V, et al
    Is dienogest the best medical treatment for ovarian endometriomas? Results of a multicentric case control study.
    Gynecol Endocrinol. 2019 Jul 16:1-3. doi: 10.1080/09513590.2019.1640674.
    PubMed     Abstract available
    
    
    
22. MUZII L, Galati G, Di Tucci C, Di Feliciantonio M, et al
    Medical treatment of ovarian endometriomas: a prospective evaluation of the effect of dienogest on ovarian reserve, cyst diameter, and associated pain.
    Gynecol Endocrinol. 2019 Jul 14:1-3. doi: 10.1080/09513590.2019.1640199.
    PubMed     Abstract available
    
    
    
23. YE H, Luo X, Pei L, Li F, et al
    The addition of single dose GnRH agonist to luteal phase support in artificial cycle frozen embryo transfer: a randomized clinical trial.
    Gynecol Endocrinol. 2019;35:618-622.
    PubMed     Abstract available
    
    
    May 2019
24. MOROTTI E, Giovanni Artini P, Persico N, Battaglia C, et al
    Metformin metabolic and vascular effects in overweight/moderately obese hyperinsulinemic PCOS patients treated with contraceptive vaginal ring: a pilot study.
    Gynecol Endocrinol. 2019 May 12:1-8. doi: 10.1080/09513590.2019.1613361.
    PubMed     Abstract available
    
    
    
25. MARTINEZ F, Rodriguez-Purata J, Clua E, Garcia S, et al
    Ovarian response in oocyte donation cycles under LH suppression with GnRH antagonist or desogestrel progestin: retrospective and comparative study.
    Gynecol Endocrinol. 2019 May 12:1-6. doi: 10.1080/09513590.2019.1604662.
    PubMed     Abstract available
    
    
    
26. MARTINEZ F, Rodriguez-Purata J, Beatriz Rodriguez D, Clua E, et al
    Desogestrel versus antagonist injections for LH suppression in oocyte donation cycles: a crossover study.
    Gynecol Endocrinol. 2019 May 7:1-6. doi: 10.1080/09513590.2019.1604661.
    PubMed     Abstract available
    
    
    April 2019
27. CARUSO S, Cianci S, Panella M, Giunta G, et al
    Comparative randomized study on the sexual function and quality of life of women on contraceptive vaginal ring containing ethinylestradiol/etonogestrel 3.47/11.00mg or 2.7/11.7mg.
    Gynecol Endocrinol. 2019 Apr 16:1-5. doi: 10.1080/09513590.2019.1603290.
    PubMed     Abstract available
    
    
    March 2019
28. FIORELLI-ARAZAWA LR, Haddad JM, Nicola MH, Machado JJDS, et al
    Hormonal oral contraceptive influence on isolation, Characterization and cryopreservation of mesenchymal stem cells from menstrual fluid.
    Gynecol Endocrinol. 2019 Mar 5:1-7. doi: 10.1080/09513590.2019.1579788.
    PubMed     Abstract available
    
    
    
29. NERI M, Pilloni M, Paoletti AM, Melis GB, et al
    Repeated two cycles of ulipristal acetate treatment improve the quality of life in premenopausal women with heavy menstrual bleeding dependent on uterine myomas, without impairment of bone health.
    Gynecol Endocrinol. 2019 Mar 1:1-6. doi: 10.1080/09513590.2019.1576618.
    PubMed     Abstract available
    
    
    February 2019
30. BARRIGA P, Vanhauwaert P, Porcile A
    Hormonal contraception and risk of breast cancer: a critical look.
    Gynecol Endocrinol. 2019 Feb 26:1-3. doi: 10.1080/09513590.2019.1576610.
    PubMed     Abstract available
    
    
    
31. SLOPIEN R, Horst N, Jaremek JD, Chinniah D, et al
    The impact of surgical treatment of obesity on the female fertility.
    Gynecol Endocrinol. 2019;35:100-102.
    PubMed     Abstract available
    
    
    January 2019
32. EKENROS L, Backstrom T, Hirschberg AL, Friden C, et al
    Changes in premenstrual symptoms in women starting or discontinuing use of oral contraceptives.
    Gynecol Endocrinol. 2019 Jan 22:1-5. doi: 10.1080/09513590.2018.1534097.
    PubMed     Abstract available
    
    
    
33. CIEBIERA M, Meczekalski B, Lukaszuk K, Jakiel G, et al
    Potential synergism between ulipristal acetate and vitamin D3 in uterine fibroid pharmacotherapy - 2 case studies.
    Gynecol Endocrinol. 2019 Jan 11:1-5. doi: 10.1080/09513590.2018.1550062.
    PubMed     Abstract available
    
    
    
34. LETE I, Doval JL, Perez-Campos E, Alonso MJ, et al
    Prevention of unintended pregnancies by using emergency contraception: the differences between levonorgestrel and ulipristal acetate. A theoretical model using data from a survey on the use of emergency contraception in Spain, 2017.
    Gynecol Endocrinol. 2019 Jan 7:1-4. doi: 10.1080/09513590.2018.1559286.
    PubMed     Abstract available
    
    
    
35. PIVA I, Brusca F, Tassinati F, Bonipozzi S, et al
    Post-abortion long-acting reversible contraception in a sample of Italian women: intrauterine device versus subdermal implant.
    Gynecol Endocrinol. 2019 Jan 2:1-7. doi: 10.1080/09513590.2018.1538343.
    PubMed     Abstract available
    
    
    December 2018
36. SABINE R, Stephanie H, Ariane G, Thomas S, et al
    Successful in vitro maturation for urgent fertility preservation despite hormonal contraception by continuous progestin application.
    Gynecol Endocrinol. 2018 Dec 31:1-3. doi: 10.1080/09513590.2018.1531985.
    PubMed     Abstract available
    
    
    November 2018
37. KUZEL D, Mara M, Zizka Z, Koliba P, et al
    Malignant endometrial polyp in woman with the levonorgestrel intrauterine system - a case report.
    Gynecol Endocrinol. 2018 Nov 19:1-3. doi: 10.1080/09513590.2018.1491028.
    PubMed     Abstract available
    
    
    
38. CONWAY F, Morosetti G, Camilli S, Martire FG, et al
    Ulipristal acetate therapy increases ultrasound features of adenomyosis: a good treatment given in an erroneous diagnosis of uterine fibroids.
    Gynecol Endocrinol. 2018 Nov 1:1-4. doi: 10.1080/09513590.2018.1505846.
    PubMed     Abstract available
    
    
    October 2018
39. WANDRESEN G, Sgarbi F, Nisihara R
    Management of contraceptives and menstrual complaints in patients with Down syndrome.
    Gynecol Endocrinol. 2018 Oct 16:1-6. doi: 10.1080/09513590.2018.1501017.
    PubMed     Abstract available
    
    
    
40. WANG YP, Ma D, Cheng XT, Zhang SJ, et al
    Comparison Of Cimicifuga foetida extract and different hormone therapies regarding in causing breast pain in early postmenopausal women.
    Gynecol Endocrinol. 2018 Oct 16:1-5. doi: 10.1080/09513590.2018.1505845.
    PubMed     Abstract available
    
    
    
41. XU Z, Meng L, Pan C, Chen X, et al
    Does oral contraceptives pretreatment affect the pregnancy outcome in polycystic ovary syndrome women undergoing ART with GnRH agonist protocol?
    Gynecol Endocrinol. 2018 Oct 10:1-4. doi: 10.1080/09513590.2018.1500535.
    PubMed     Abstract available
    
    
    September 2018
42. MIAO J, Yan Q, Wang L, Wang X, et al
    Three cases of transient hyperthyroidism after triptorelin treatment - case report and literature review.
    Gynecol Endocrinol. 2018;34:734-735.
    PubMed     Abstract available
    
    
    July 2018
43. VUJOVIC S, Ivovic M, Tancic-Gajic M, Marina L, et al
    Endometrium receptivity in premature ovarian insufficiency - how to improve fertility rate and predict diseases?
    Gynecol Endocrinol. 2018 Jul 25:1-5. doi: 10.1080/09513590.2018.1490715.
    PubMed     Abstract available
    
    
    May 2018
44. STUMPF MAM, Kluthcovsky ACGC, Okamoto JM, Schrut GCA, et al
    Acute pancreatitis secondary to oral contraceptive-induced hypertriglyceridemia: a case report.
    Gynecol Endocrinol. 2018 May 21:1-3. doi: 10.1080/09513590.2018.1473365.
    PubMed     Abstract available
    
    
    
45. RODRIGUEZ-PURATA J, Devesa M, Parriego M, Pardos C, et al
    Linking back-to-back stimulation cycles with oral contraceptives or progestins in women undergoing embryo accumulation for preimplantation genetic testing, a retrospective study.
    Gynecol Endocrinol. 2018 May 17:1-6. doi: 10.1080/09513590.2018.1473363.
    PubMed     Abstract available
    
    
    
46. JEONG SH, Lee D, Kim SK, Jee BC, et al
    Symptom-alleviating effect and adverse effect of dienogest in Korean women with endometriosis.
    Gynecol Endocrinol. 2018 May 7:1-5. doi: 10.1080/09513590.2018.1469610.
    PubMed     Abstract available
    
    
    
47. FULGHESU AM, Melis F, Murru G, Canu E, et al
    Very low dose of flutamide in the treatment of hyperandrogenism.
    Gynecol Endocrinol. 2018;34:394-398.
    PubMed     Abstract available
    
    
    April 2018
48. MANIGLIO P, Ricciardi E, Meli F, Tomao F, et al
    Complete remission of cerebral endometriosis with dienogest: a case report.
    Gynecol Endocrinol. 2018 Apr 20:1-3. doi: 10.1080/09513590.2018.1463362.
    PubMed     Abstract available
    
    
    
49. ALTINOK ML, Ravn P, Andersen M, Glintborg D, et al
    Effect of 12-month treatment with metformin and/or oral contraceptives on health-related quality of life in polycystic ovary syndrome.
    Gynecol Endocrinol. 2018 Apr 16:1-5. doi: 10.1080/09513590.2018.1460343.
    PubMed     Abstract available
    
    
    January 2018
50. BRICHANT G, Nervo P, Albert A, Munaut C, et al
    Heterogeneity of estrogen receptor alpha and progesterone receptor distribution in lesions of deep infiltrating endometriosis of untreated women or during exposure to various hormonal treatments.
    Gynecol Endocrinol. 2018 Jan 31:1-5. doi: 10.1080/09513590.2018.1433160.
    PubMed     Abstract available
    
    
    
51. HERSHKO KLEMENT A, Frederic M, Bentov Y, Chang P, et al
    Oral contraceptive pills as an option for non-surgical management of retained products of conception - a preliminary study.
    Gynecol Endocrinol. 2018 Jan 18:1-3. doi: 10.1080/09513590.2018.1427714.
    PubMed     Abstract available
    
    
    
52. MORGANTE G, Massaro MG, Di Sabatino A, Cappelli V, et al
    Therapeutic approach for metabolic disorders and infertility in women with PCOS.
    Gynecol Endocrinol. 2018;34:4-9.
    PubMed     Abstract available
    
    
    December 2017
53. ESTADELLA J, Espanol P, Ascencio F, Perello J, et al
    Ulipristal acetate for the management of acute heavy menstrual bleeding without fibroids.
    Gynecol Endocrinol. 2017 Dec 20:1-4. doi: 10.1080/09513590.2017.1417376.
    PubMed     Abstract available
    
    
    
54. NERI M, Piras B, Paoletti AM, Vallerino V, et al
    Long-acting reversible contraception (LARC) with the intrauterine system with levonorgestrel (6 mcg/d): observational study on the acceptability, quality of life, and sexuality in Italian women.
    Gynecol Endocrinol. 2017 Dec 19:1-4. doi: 10.1080/09513590.2017.1416465.
    PubMed     Abstract available
    
    
    November 2017
55. MABROUK M, Paradisi R, Arena A, Del Forno S, et al
    Short-term histopathological effects of dienogest therapy on ovarian endometriomas: in vivo, nonrandomized, controlled trial.
    Gynecol Endocrinol. 2017 Nov 21:1-5. doi: 10.1080/09513590.2017.1405932.
    PubMed     Abstract available
    
    
    October 2017
56. JIN P, Xie Y
    Treatment strategies for women with polycystic ovary syndrome.
    Gynecol Endocrinol. 2017 Oct 31:1-6. doi: 10.1080/09513590.2017.1395841.
    PubMed     Abstract available
    
    
    September 2017
57. SZUBERT M, Zietara M, Suzin J
    Conservative treatment of deep infiltrating endometriosis: review of existing options.
    Gynecol Endocrinol. 2017 Sep 27:1-5. doi: 10.1080/09513590.2017.1381837.
    PubMed     Abstract available
    
    
    
58. BALDANI DP, Skrgatic L, Ougouag R, Kasum M, et al
    The cardiometabolic effect of current management of polycystic ovary syndrome: strategies of prevention and treatment.
    Gynecol Endocrinol. 2017 Sep 23:1-5. doi: 10.1080/09513590.2017.1381681.
    PubMed     Abstract available
    
    
    
59. MODAFFARI P, D'alonzo M, Garbagnati M, Pecchio S, et al
    Unexpected uterine leiomyosarcoma in a woman with multiple myomas treated with ulipristal acetate: case report and literature review.
    Gynecol Endocrinol. 2017 Sep 21:1-3. doi: 10.1080/09513590.2017.1380186.
    PubMed     Abstract available
    
    
    June 2017
60. KIM SW, Kim H, Ku SY, Suh CS, et al
    A successful live birth with in vitro fertilization and thawed embryo transfer after conservative treatment of recurrent endometrial cancer.
    Gynecol Endocrinol. 2017 Jun 26:1-5. doi: 10.1080/09513590.2017.1342239.
    PubMed     Abstract available
    
    
    
61. SABBIONI L, Petraglia F, Luisi S
    Non-contraceptive benefits of intrauterine levonorgestrel administration: why not?
    Gynecol Endocrinol. 2017 Jun 6:1-8. doi: 10.1080/09513590.2017.1334198.
    PubMed     Abstract available
    
    
    May 2017
62. NERI M, Malune ME, Corda V, Piras B, et al
    Body composition and psychological improvement in healthy premenopausal women assuming the oral contraceptive containing micronized estradiol (E2) and nomegestrol acetate (NOMAC).
    Gynecol Endocrinol. 2017 May 9:1-5. doi: 10.1080/09513590.2017.1322574.
    PubMed     Abstract available
    
    
    April 2017
63. BAS-LANDO M, Rabinowitz R, Farkash R, Algur N, et al
    Prediction value of anti-Mullerian hormone (AMH) serum levels and antral follicle count (AFC) in hormonal contraceptive (HC) users and non-HC users undergoing IVF-PGD treatment.
    Gynecol Endocrinol. 2017 Apr 28:1-4. doi: 10.1080/09513590.2017.1320376.
    PubMed     Abstract available
    
    
    
64. KEBAPCILAR AG, Ilhan TT, Dursunoglu D, Kebapcilar L, et al
    Efficacy comparison of oral rosuvastatin versus oral progesterone and bevacizumab on regression of surgically endometriotic implants in rats.
    Gynecol Endocrinol. 2017 Apr 28:1-5. doi: 10.1080/09513590.2017.1320384.
    PubMed     Abstract available
    
    
    
65. MOROTTI E, Casadio P, Guasina F, Battaglia B, et al
    Weight gain, body image and sexual function in young patients treated with contraceptive vaginal ring. A prospective pilot study.
    Gynecol Endocrinol. 2017 Apr 17:1-5. doi: 10.1080/09513590.2017.1306850.
    PubMed     Abstract available
    
    
    
66. GRANDI G, Mueller MD, Bersinger NA, Facchinetti F, et al
    The association between progestins, nuclear receptors expression and inflammation in endometrial stromal cells from women with endometriosis.
    Gynecol Endocrinol. 2017 Apr 17:1-4. doi: 10.1080/09513590.2017.1314458.
    PubMed     Abstract available
    
    
    March 2017
67. SANT'ANNA GD, Brum IS, Branchini G, Pizzolato LS, et al
    Ovarian steroid hormones modulate the expression of progesterone receptors and histone acetylation patterns in uterine leiomyoma cells.
    Gynecol Endocrinol. 2017 Mar 16:1-5. doi: 10.1080/09513590.2017.1301924.
    PubMed     Abstract available
    
    
    
68. TANMAHASAMUT P, Saejong R, Rattanachaiyanont M, Angsuwathana S, et al
    Postoperative desogestrel for pelvic endometriosis-related pain: a randomized controlled trial.
    Gynecol Endocrinol. 2017 Mar 7:1-6. doi: 10.1080/09513590.2017.1296124.
    PubMed     Abstract available
    
    
    January 2017
69. WILDEMEERSCH D, Goldstuck ND, Jackers G
    Results of a 5-year contraceptive trial in parous and nulliparous women with a new LNG-IUS.
    Gynecol Endocrinol. 2017 Jan 13:1-4. doi: 10.1080/09513590.2016.1276164.
    PubMed     Abstract available
    
    
    
70. MULLER V, Kogan I, Yarmolinskaya M, Niauri D, et al
    Dienogest treatment after ovarian endometrioma removal in infertile women prior to IVF.
    Gynecol Endocrinol. 2017;33.
    PubMed     Abstract available
    
    
    December 2016
71. GUIDA M, Di Carlo C, Troisi J, Gallo A, et al
    The sexuological impact of hormonal contraceptives based on their route of administration.
    Gynecol Endocrinol. 2016.
    PubMed     Abstract available
    
    
    November 2016
72. BASTIANELLI C, Farris M, Bruno Vecchio RC, Rosato E, et al
    An observational study of adherence to combined oral contraceptive regimens.
    Gynecol Endocrinol. 2016.
    PubMed     Abstract available
    
    
    September 2016
73. SHARIFZADEH F, Aminimoghaddam S, Kashanian M, Fazaeli M, et al
    A comparison between the effects of metformin and megestrol on simple endometrial hyperplasia.
    Gynecol Endocrinol. 2016.
    PubMed     Abstract available
    
    
    June 2016
74. SEIKKULA J, Anttila L, Polo-Kantola P, Bloigu R, et al
    Effect of mid-luteal phase GnRH agonist on frozen-thawed embryo transfers during natural menstrual cycles: a randomised clinical pilot study.
    Gynecol Endocrinol. 2016.
    PubMed     Abstract available
    
    
    January 2016
75. FENG W, Jia YY, Zhang DY, Shi HR, et al
    Management of polycystic ovarian syndrome with Diane-35 or Diane-35 plus metformin.
    Gynecol Endocrinol. 2016;32:147-50.
    PubMed     Abstract available
    
    
    
76. DAKHLY DM, Bayoumi YA, Gad Allah SH
    Which is the best IVF/ICSI protocol to be used in poor responders receiving growth hormone as an adjuvant treatment? A prospective randomized trial.
    Gynecol Endocrinol. 2016;32:116-9.
    PubMed     Abstract available
    
    
    
77. PAOLETTI AM, Lello S, Di Carlo C, Orru M, et al
    Effect of Estradiol valerate plus dienogest on body composition of healthy women in the menopausal transition: a prospective one-year evaluation.
    Gynecol Endocrinol. 2016;32:61-4.
    PubMed     Abstract available
    
    
    
78. LAGANA AS, Giacobbe V, Triolo O, Granese R, et al
    Dienogest as preoperative treatment of submucous myomas for hysteroscopic surgery: a prospective, randomized study.
    Gynecol Endocrinol. 2016;32:408-11.
    PubMed     Abstract available
    
    
    December 2015
79. SAITO F, Tashiro H, Yamaguchi M, Honda R, et al
    Development of a mouse model for testing therapeutic agents: the anticancer effect of dienogest on endometrial neoplasms.
    Gynecol Endocrinol. 2015.
    PubMed     Abstract available
    
    
    July 2015
80. POLYZOS NP, Corona R, Van De Vijver A, Blockeel C, et al
    Corifollitropin alfa followed by hpHMG in GnRH agonist protocols. Two prospective feasibility studies in poor ovarian responders.
    Gynecol Endocrinol. 2015.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Contraception and Contraceptive Drugs is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: